Submitted by reuters8361 in business
Moderna <a href="https://www.reuters.com/markets/companies/MRNA.O" target="_blank">(MRNA.O)</a> on Thursday said its 2023 sales would only hit the low end of its $6 billion to $8 billion forecast, reflecting weaker demand for COVID-19 vaccines, and its shares…